Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Oncology
Authors: Pierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan List, Steven D Gore, John F Seymour, John M Bennett, John Byrd, Jay Backstrom, Linda Zimmerman, David McKenzie, CL Beach, Lewis R Silverman
Institutions: Université Sorbonne Paris Nord, Hôpital Avicenne, King's College Hospital, Karolinska University Hospital, Azienda Ospedaliero-Universitaria Careggi, University Hospital Schleswig-Holstein, Düsseldorf University Hospital, Hospital Universitari i Politècnic La Fe, Moffitt Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The University of Melbourne, Peter MacCallum Cancer Centre, University of Rochester Medicine, The Ohio State University, Celgene (United States), Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Celgene, National Cancer Institute
OpenAlex ID: W2118771330